Related Experiment Video
Updated: Jul 26, 2025

08:14
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
15.7K
Age prediction from human blood plasma using proteomic and small RNA data: a comparative analysis
Jérôme Salignon1,2, Omid R Faridani1,3,4, Tasso Miliotis5
1Department of Medicine, Integrated Cardio Metabolic Centre (ICMC), Karolinska Institutet, Huddinge 14157, Sweden.
Aging
|June 21, 2023
Summary
Combining proteomic and microRNA data significantly improves age prediction accuracy. This integrated approach offers a more comprehensive view of aging than individual molecular types, paving the way for better aging clocks.
Area of Science:
- Biomarkers of Aging
- Molecular Biology
- Proteomics
- Genomics
Background:
- Aging clocks utilize molecular data for applications in medicine, forensics, and ecology.
- Limited research compares different molecular data types for age prediction within the same cohort.
- Investigating combined molecular data for enhanced age prediction is crucial.
Purpose of the Study:
- To compare the efficacy of proteins and small RNAs (specifically microRNAs) in predicting biological age.
- To determine if combining proteomic and microRNA data improves age prediction accuracy.
- To identify age-associated proteins and microRNAs in human blood plasma.
Main Methods:
- Mass spectrometry was used to quantify 612 proteins, identifying 21 age-related proteins.
- Small RNA sequencing identified 315 age-related small RNAs, predominantly microRNAs.
- Age-predictive models were built using proteomic data, microRNA data, and a combination of both.
Main Results:
- Proteins provided the most accurate age prediction model (R² = 0.59 ± 0.02).
- MicroRNAs (miRNAs) were the best-performing small RNAs, with R² = 0.54 ± 0.02.
- Combining protein and miRNA data significantly improved age prediction (R² = 0.70 ± 0.01).
Conclusions:
- Combined proteomic and miRNA data yield superior age predictions compared to individual molecular types.
- This integrated approach may capture a broader spectrum of age-related physiological changes.
- Further validation with larger sample sizes is needed to confirm these findings for developing future aging clocks.

